Survival After Secondary Prevention Implantable Cardioverter-Defibrillator Placement: An Analysis From the NCDR ICD Registry.

[1]  National Cardiovascular Data Registry (NCDR®) , 2019 .

[2]  H. Bøtker,et al.  Thirteen-year nationwide trends in use of implantable cardioverter-defibrillators and subsequent long-term survival. , 2015, Heart rhythm.

[3]  K. Anstrom,et al.  Survival After Primary Prevention Implantable Cardioverter-Defibrillator Placement Among Patients With Chronic Kidney Disease , 2014, Circulation. Arrhythmia and electrophysiology.

[4]  R. Greenlee,et al.  Temporal Trends in Patient Characteristics and Outcomes Among Medicare Beneficiaries Undergoing Primary Prevention Implantable Cardioverter-Defibrillator Placement in the United States, 2006–2010: Results from the National Cardiovascular Data Registry’s Implantable Cardioverter-Defibrillator Registr , 2014, Circulation.

[5]  J. Healey,et al.  Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly , 2013, Circulation.

[6]  John Rumsfeld,et al.  The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. , 2013, Heart rhythm.

[7]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[8]  K. Anstrom,et al.  Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. , 2013, JAMA.

[9]  J. Messenger,et al.  The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012. , 2012, Journal of the American College of Cardiology.

[10]  P. Austin,et al.  Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database , 2012, Annals of Internal Medicine.

[11]  Jeroen J. Bax,et al.  Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  M. Gold.  Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT) , 2010 .

[13]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[14]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[15]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[16]  R. White,et al.  Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation ☆ , 2003 .

[17]  Douglas L Packer,et al.  Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. , 2003, The New England journal of medicine.

[18]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[19]  Mark E. Hill,et al.  The Social Security Administration's Death Master File: the completeness of death reporting at older ages. , 2001, Social security bulletin.

[20]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[21]  R. Cappato,et al.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). , 2000, Circulation.

[22]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[23]  R. Cappato,et al.  A Randomized Comparison of Antiarrhythmic Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Cardiac Arrest: the Cardiac Arrest , 2000 .

[24]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[25]  F. Trovarelli,et al.  Medical Therapy , 1970 .